The impact of cannabis use on patient outcomes post immune c — 2025 Clinical Trial | BudProfiles
InconclusiveClinical Trial2025
The impact of cannabis use on patient outcomes post immune checkpoint inhibitor (ICI) therapy in a longitudinal observational trial: The DiRECT Cohort.
Caffeine, nicotine, cannabis, and psilocybin: Pharmacology, toxicology, and potential therapeutic uses of four naturally occurring psychoactive substances